NCT07345780 2026-01-16Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological MalignanciesTongji HospitalPhase NA Not yet recruiting28 enrolled